source
- GSK drops Phase 3 chronic cough drug in a blow to $2B Bellus Health buyoutIn a major stumble for GSK’s $2 billion acquisition of Bellus Health, the UK pharma said Friday it is ending development of camlipixant in refractory chronic cough (RCC) after the drug ...Endpoints · 27d ago↗ source
- Zealand Pharma gets its US marketing leader from Lilly; Bexorg turns to Biohaven for CSO hire→ Silvia Luque announced on LinkedIn that she was named head of US marketing at Zealand Pharma after 13 years in various roles at obesity competitor Eli Lilly. She had been ...Endpoints · 27d ago↗ source
- Thoracic Stent Graft Recall: Bolton Medical Removes Relay Pro SystemAffected grafts may not unclasp from the delivery system. This may require conversion to open surgical repair and can result in patient death.